APA (7th ed.) Citation

Yu, N., Hwang, M., Ahn, B. C., Lee, Y., Hong, S., Sim, H., . . . Han, J. Longitudinal pharmacogenomic analysis of refractory lung cancer to identify therapeutic candidates for epidermal growth factor receptor–tyrosine kinase inhibitor resistance subclones. Nature Publishing Group.

Chicago Style (17th ed.) Citation

Yu, Namhee, et al. Longitudinal Pharmacogenomic Analysis of Refractory Lung Cancer to Identify Therapeutic Candidates for Epidermal Growth Factor Receptor–tyrosine Kinase Inhibitor Resistance Subclones. Nature Publishing Group.

MLA (9th ed.) Citation

Yu, Namhee, et al. Longitudinal Pharmacogenomic Analysis of Refractory Lung Cancer to Identify Therapeutic Candidates for Epidermal Growth Factor Receptor–tyrosine Kinase Inhibitor Resistance Subclones. Nature Publishing Group.